No abstract available
Keywords:
Cytomegalovirus treatment; Ganciclovir resistance; Maribavir; Primary immunodeficiency.
MeSH terms
-
Administration, Oral
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / pharmacology
-
Antiviral Agents / therapeutic use*
-
Benzimidazoles / administration & dosage
-
Benzimidazoles / pharmacology
-
Benzimidazoles / therapeutic use*
-
Blood / virology
-
Cytomegalovirus / drug effects*
-
Cytomegalovirus Infections / drug therapy*
-
Drug Resistance, Viral / genetics*
-
Ganciclovir / therapeutic use
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Isoxazoles / therapeutic use
-
Leflunomide
-
Male
-
Middle Aged
-
Ribonucleosides / administration & dosage
-
Ribonucleosides / pharmacology
-
Ribonucleosides / therapeutic use*
-
Sputum / virology
-
Time Factors
Substances
-
Antiviral Agents
-
Benzimidazoles
-
Immunosuppressive Agents
-
Isoxazoles
-
Ribonucleosides
-
Leflunomide
-
Ganciclovir
-
maribavir